Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 30, 2021 at 05:05 pm
Share
Sunmax Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 855.851 million compared to TWD 594.145 million a year ago. Operating income was TWD 332.314 million compared to TWD 175.055 million a year ago. Net income was TWD 238.077 million compared to TWD 100.447 million a year ago. Basic earnings per share was TWD 4.37 compared to TWD 1.84 a year ago.
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.
SUNMAX BIOTECHNOLOGY CO., LTD. 
